1 / 50

Inflammation and white matter diseases

Inflammation and white matter diseases. Infection: an approach based on location:. Infections of the epidural space: epidural empyema Infections of the subdural space: subdural empyema Infections of the subarachnoid space: (lepto)meningitis

bendek
Télécharger la présentation

Inflammation and white matter diseases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Inflammation and white matter diseases

  2. Infection: an approach based on location: • Infections of the epidural space: epidural empyema • Infections of the subdural space: subdural empyema • Infections of the subarachnoid space: (lepto)meningitis • Infections of the brain itself: abscess and encephalitis

  3. Subarachnoid infection (leptomeningitis) Bacterial infection: purulent meningitis - the arrival of bacteria triggers a classical inflammatory process - it is associated with a generalized cerebral edema: major complication of the acute phase - the process extends in the perivascular spaces ( Virchow-Robin ), and also in the ventricular system via the foramina of Magendie and Luschka

  4. PUS

  5. Viral encephalitis: common histological findings - Inflammatory infiltrate in the subarachnoid space, around the blood vessels (perivascular cuffing) and in the parenchyma - microglial proliferation, diffuse or focal - reactive gliosis - neuronal changes: necrosis, neuronophagy - viral inclusions in neurons, astrocytes or oligodendrocytes

  6. Prion diseases Prion diseases TSE's in animals TSE's in man sporadic 85% Scrapie sCJD }14% genetic fCJD ex-Scr acq. by infection GSS CWD FFI TME }1% Kuru BSE iCJD FSE vCJD ex-TSE

  7. Prion diseases • disease where normal prion protein is misfolded (from PrPC to PrPSc) • PrPSc forms aggregates which are a template to transform more PrPC to PrPSc • Original cause can be genetic, infectious or sporadic • Function of PrPC is unknown

  8. Prion diseases • Can affect all grey matter in the brain leading to rapid progressive disease with one or more of: • Dementia (cerebral cortex) • Spasticity (cerebral cortex) • Myoclonus (cerebral cortex) • Cortical blindness • Extrapyramidal signs (basal ganglia, SN) • Ataxia (cerebellum) • Pathology: • Vacuoles • Neuronal loss • Gliosis • Prion protein deposition (sometimes as amyloid plaques)

  9. Againts virus hypothesis • Very resistant agent: • resists dry heat ( > 200ºC) • resists steam autoclaving (up to134ºC, 18 mins.) • resists formaldehyde • resists UV-radiation • resists Gamma-radiation ( > 0.3 MGray) • etc.

  10. Prion theory (Prusiner) • In biochemical separation-infection studies: • Infectivity is not present in a DNA/RNA fraction • Infectivity is present in a protein fraction • In conclusion: • A protein (and that protein only) causes a prion disease

  11. Sporadic Creutzfeldt-Jakob disease diagnosis • Rare disease: 1/106 • Duration: short (months) • Neurological signs and symptoms: Rapidly progressive dementia, myoclonus, ataxia, central visual disturbances, extrapyramidal signs, pyramidal signs, akinetic mutism (variant: chorea, dysesthesias, psychiatric disturbances) • EEG and MRI • Neuropathology • WHO criteria: • Type of CJD (sporadic, genetic, iatrogenic, variant) • Strength of diagnosis (definite, probable, possible)

  12. Gross abnormalities: mostly not

  13. Microscopy of Creutzfeldt-Jakob disease

  14. Familial CJD vs Familial Fatal Insomnia 178Asn-129V-f-CJD 178Asn-129M-FFI

  15. Prion diseases acquired through infection • Kuru • iatrogenic CJD • new variant CJD

  16. Kuru

  17. Etiology of Kuru • Primary infectious: no fever, no CSF cell raise • Genetic disease: • Pro: in families, in patients who moved out of Fore region. • Con: also in patients who came to live in Fore region, as well in young as in old patients. • Toxic/deficiency: no toxic compound isolated, balanced diet. • Endocanibalism

  18. iCJD number incubation time clinical presentation Intracerebral cornea neurosurgery stereotactic EEG Cerebral surface dura mater* Peripheral blood growth hormone gonadotrophin 4 5 2 174 180 4 17 mo 17 mo 18 mo 6-12 y 12 y 13 y dementia/ataxia dementia/ataxia dementia/ataxia ataxia ataxia ataxia * Mostly Lyodura, now 2 cases with 0.1 N NaOH treated Tutoplast

  19. Bovine Spongiform Encephalopathy

  20. Clinical history in v-CJD • 65% of cases onset with ‘psychiatric’ complaints: • Behavioural disturbance • Attention deficit • Personality changes • Depression • Later weeks - months: • Dysaesthesia (20 % onset with dysaesth) • Ataxia • Myoclonus/choreo-athetosis • Progressive dementia • No typical EEG • 14-3-3 protein 50% of the cases positive • bilateral Pulvinar sign on MRI

  21. Age Comparison with sp-CJD

  22. vCJD autopsy

  23. Tonsil biopsies in vCJD

  24. Proposed route of peripheral infection GALT > Spleen B-cell + + Macroph. FDC Macroph. FDC M-cell lymphatics Symp NS Xth CN Gut Spinal cord Brainstem Brain

  25. Protein misfolding to neuronal dysfunction pathogenesis Protein misfolding & accumulation diseases: • Alzheimer’s disease • Parkinson’s disease • Tauopathies • Progressive Supranuclear palsy • Fronto-temporal dementias • Cortico-basal degeneration

  26. Multiple sclerosis (MS) • Frequently onset in younger individuals (20-40 yoa) • F>M • Exacerbations and remissions (with often only partial remission later in the course) • Locations: central myelin—with symtoms of function loss. • Often initial symptom: visual field defect

  27. Young plaque

  28. Chronic plaque

  29. Pathogenesis • T cell mediated auto immune disease • Recent hypothesis: venous congestion due to vascular abnormalities of the neck

More Related